Solace Therapeutics Secures $13,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
    Solace Therapeutics
  • Mailing Address
    135 Newbury Street Framingham, MA 01701 USA
  • Company Description
    Solace Therapeutics is developing a non-surgical device specifically for the treatment of Stress Urinary Incontinence (SUI).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy